Technology Landscape Study on CRISPR-Cas9

Although CRISPR was known to have an important role in bacterial immunity for over a decade, it is only in the last 5 years that it has garnered interest as a gene editing tool. Increasing investment in this field is indicative of global market opportunities for CRISPR-Cas9 over existing alternatives. The objective of this study is to explore the market and patenting activity in CRISPR-Cas9 gene editing technology. This study considers issued patents and pending published applications related to CRISPR-Cas9 published since January 1, 2007. Search strategies using various combinations of keywords, classification codes, and prominent assignees resulted in more

Continue reading

Want your patent renewals to be cost-effective? Consider these tips

IP strategists suggest that having a right strategy in place right from the outset of invention disclosure will help companies cut down their overall patent maintenance costs. With a little planning and preparation, you can learn how to manage your costs and achieve significant savings. Established companies, regardless of their assets or market values, look for every possible way to reduce direct and indirect costs. Patent renewal is one area where innovative companies hunt for opportunities to reduce the maintenance costs as much as possible. Anyone familiar with patent renewals would know how painful a process it can be and

Continue reading

Increasing Patent Allowance Rate Using an Optimized Invention Management Solution

Huge sums of time and money are invested to support ongoing research and development efforts globally, particularly in the most innovative industries like pharma, healthcare and biotechnology. The global R&D spending [1] is at a record high of US$1.7 trillion of which 80% of total spending is only from the Top 10 countries. While these statistics may suggest increased intensity of companies in R&D spending, we should also understand that these efforts will only yield returns when they are awarded enforceable ownership through exclusive patent rights. Intellectual property rights, especially patents, help companies protect their business interests by allowing them to

Continue reading

Acquisition and Predictive Analysis

It’s been a busy year for mergers and acquisitions, with a number of billion dollar deals that happened. We tracked and analyzed over 700 Mergers & Acquisitions that occurred in 2017 and extracted the 20 largest deals across 9 industries, valued above $5 B. $274.9B in large M&A transactions took place in 2017. 42% of the transactions occurred in the Medical/Pharma Sector totaling $86.6 B across 8 events. 21% of the transactions occurred in the Energy Sector totaling $28.3 B across 4 events. The largest acquisition in the most active sector: Medical equipment/Pharma was J&J | Actelion at $30B. The largest acquisition

Continue reading

Is your patent getting the life it deserves?

Patent Term Adjustments (PTAs) alter the patent term and are meant to account for delays in patent prosecution, and usually increase the life of the patent beyond their normal 20 year term. They are usually calculated by accounting for prosecution delays by both the applicant and the USPTO. The PTO automatically grants adjustments, but patentees can petition to recalculate the adjustment if they disagree with the PTO’s calculation. In our own experience, USPTO miscalculations, though rare, can be quite significant. In some of these cases, recalculation led to an addition of several hundred days to the life of the patent.

Continue reading

Artificial Intelligence Innovation: A Case Study

by Deepa R. Krishna and Mark O’Donnell Introduction: The artificial intelligence (AI) landscape is growing quickly.  Artificial intelligence startups raised $5B in 2016, a 10-fold increase since 2012.[1]  Tech giants (Google, Microsoft, IBM) are contributing heavily to this acceleration, both in academic and practical pursuits.  Google published 218 papers on machine learning in 2016, nearly double the number of publications in 2014.[2]  In December 2016, Microsoft launched a new venture fund specifically to evaluate and fund AI startups, kicking off the fund with an investment in Element AI, then acquiring Maluuba just one month later. [3] [4] For professional advisors

Continue reading

MaxVal Patent Litigation Databank expands coverage to include Global Patent Litigation Data

MaxVal, a leading technology-enabled IP solutions provider known for its cutting edge products and automated solutions announces the global data expansion of MaxVal’s Litigation Databank with the inclusion of valuable non-US litigation data. MaxVal’s Litigation Databank is an exhaustive collection of litigation data including cases of US District Courts, Court of Appeals for the Federal Circuit, International Trade Commission, Supreme Court and PTAB (Patent Trial and Appeal Board). MaxVal’s Litigation data already provide insights for some of the leading patent analytics providers including WIPS, IP.com, PatSnap.com and Aistemos as well as industry innovators such as Unified Patents. MaxVal’s global patent

Continue reading